drugset / Trial / NCT02314546

Intranasal Midazolam in Children as a Pre-Operative Sedative

NCT02314546 ↗

Phase 4 Completed 15 enrolled Bassett Healthcare
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.

Timeline

Start
2011-12
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 4 % —
Comparator Midazolam Small molecule 0.2 mg/kg Intranasal

Indications

No indication recorded.